Ra Pharmaceuticals (RARX) reports Q4 loss per share of 47c, announces significant progress on its first XR formulation of zilucoplan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Ra Pharmaceuticals (RARX) reports Q4 loss per share of 47c, announces significant progress on its first XR formulation of zilucoplan
(NASDAQ: RARX) Delayed: 48.00 --0 (-0%)
Previous Close $48.00    52 Week High $14.86 
Open $2.00    52 Week Low $12.33 
Day High $48.00    P/E N/A 
Day Low $48.00    EPS $0.00 
Volume 10